(Q34210699)

31 July 2017

1 reference

title

Hepatitis C viral dynamics (English)

1 reference

31 July 2017

1 reference

Layden TJ

1

1 reference

31 July 2017

Lam NP

series ordinal

2

1 reference

31 July 2017

Wiley TE

series ordinal

3

1 reference

31 July 2017

publication date

1 November 1999

1 reference

31 July 2017

published in

Clinics in liver disease

1 reference

31 July 2017

volume

3

1 reference

31 July 2017

issue

4

1 reference

31 July 2017

page(s)

793-810

1 reference

Detection of widespread hepatocyte infection in chronic hepatitis C.

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970239-7

7 January 2021

Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970239-7

7 January 2021

Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C. International Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970239-7

7 January 2021

Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970239-7

7 January 2021

Viral dynamics of hepatitis C early after orthotopic liver transplantation: evidence for rapid turnover of serum virions.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970239-7

7 January 2021

Sequential serum hepatitis C viral RNA levels longitudinally assessed by branched DNA signal amplification

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970239-7

7 January 2021

Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970239-7

7 January 2021

The interferon sensitivity determining region: all hepatitis C virus isolates are not the same

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970239-7

7 January 2021

Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970239-7

7 January 2021

Hepatitis C virus genotypes 1 and 2 respond to interferon-alpha with different virologic kinetics.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970239-7

7 January 2021

Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970239-7

7 January 2021

Dose-dependent acute clearance of hepatitis C genotype 1 virus with interferon alfa

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970239-7

7 January 2021

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970239-7

7 January 2021

Intrahepatic hepatitis C virus-specific cytotoxic T lymphocyte activity and response to interferon alfa therapy in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970239-7

7 January 2021

Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970239-7

7 January 2021

Fluctuations in viral load (HCV RNA) are relatively insignificant in untreated patients with chronic HCV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970239-7

7 January 2021

Viral dynamics in hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970239-7

7 January 2021

Loss of serum HCV RNA at week 4 of interferon‐α therapy is associated with more favorable long‐term response in patients with chronic hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970239-7

7 January 2021

Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970239-7

7 January 2021

HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970239-7

7 January 2021

Decay characteristics of HIV-1-infected compartments during combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970239-7

7 January 2021

Disappearance of serum hepatitis C virus RNA within two days after one dose interferon administration is predictive for response to high-dose interferon-alpha 2b treatment for chronic hepatitis C. Keio Interferon-alpha 2b Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970239-7

7 January 2021

Viral dynamics in human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970239-7

7 January 2021

Early HCV RNA values after interferon predict response

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970239-7

7 January 2021

Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970239-7

7 January 2021

Dynamics of hepatitis C viremia following interferon-alpha administration

1 reference

https://api.crossref.org/works/10.1016%2FS1089-3261%2805%2970239-7

7 January 2021

10.1016/S1089-3261(05)70239-7

Identifiers

DOI

1 reference

31 July 2017

1 reference